[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:combined-d-2-hydroxyglutaric-aciduria-and-l-2-hydroxyglutaric-aciduria":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Combined D-2-hydroxyglutaric aciduria and L-2-hydroxyglutaric aciduria",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07125066","An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)",[11],"Phase 1","ENROLLING_BY_INVITATION","2026-08-03T03:25:11.951163Z","2026-06-16T05:54:07.855362Z",[],[]]